Skip to main content
Top
Published in: Sports Medicine 6/2000

01-06-2000 | Leading Article

Perspectives in the Utilisation of Fourier-Transform Infrared Spectroscopy of Serum in Sports Medicine

Health Monitoring of Athletes and Prevention of Doping

Authors: Cyril Petibois, Professor Gérard Déléris, Georges Cazorla

Published in: Sports Medicine | Issue 6/2000

Login to get access

Abstract

Doping prevention is mainly directed to providing information on the dangers of doping to young athletes and to every profession concerned with athletic performance. Unfortunately, repression is also necessary in the fight against doping. Measurement of performance-enhancing drugs is complex, partly because of the large number of prohibited substances. A number of sophisticated analytical techniques are increasingly being used to provide the maximum detection time window. However, the effectiveness of methods to separate exogenous from endogenous biological molecules and the cost of antidoping analyses makes controls invalid or impossible. Moreover, most athletes, because of the metabolic and psychological stresses caused, legitimately refuse blood testing. It is becoming crucial to introduce new methods in the form of longitudinal health monitoring, since this is probably the most effective tool to prevent the use of doping agents when athletes become overtrained and/or overstressed.
This paper describes new methods using Fourier-transform infrared spectroscopy to analyse serum from 50μl samples of capillary blood. This technique has been shown to allow determination of the concentration of a wide range of biological molecules in a single microsample with clinically useful accuracy, and to provide a ‘discriminatory biomolecular profile’ to differentiate individuals on the basis of their physiological status. A specific application of this methodology is to perform longitudinal health monitoring in athletes, allowing prevention of overtraining. It is proposed to apply such methods in longitudinal studies for health monitoring and prevention of doping.
Literature
1.
go back to reference Henderson JM. Therapeutic drugs: what to avoid with athletes. Clin Sports Med 1998; 17 (2): 229–43PubMedCrossRef Henderson JM. Therapeutic drugs: what to avoid with athletes. Clin Sports Med 1998; 17 (2): 229–43PubMedCrossRef
2.
go back to reference Catlin H, Murray TH. Performance-enhancing drugs, fair competition, and Olympic sport. JAMA 1996; 276: 231–7PubMedCrossRef Catlin H, Murray TH. Performance-enhancing drugs, fair competition, and Olympic sport. JAMA 1996; 276: 231–7PubMedCrossRef
3.
go back to reference Hemmersbach P, de la Torre R. Stimulants, narcotics and beta-blockers: 25 years of development in analytical techniques for doping control. J Chromatogr B Biomed Appl 1996; 687 (1): 221–38PubMedCrossRef Hemmersbach P, de la Torre R. Stimulants, narcotics and beta-blockers: 25 years of development in analytical techniques for doping control. J Chromatogr B Biomed Appl 1996; 687 (1): 221–38PubMedCrossRef
4.
go back to reference Ayotte CD, Goudreault D, Charlebois A. Testing for natural and synthetic anabolic agents in human urine. J Chromatogr B Biomed Appl 1996; 687 (1): 3–25PubMedCrossRef Ayotte CD, Goudreault D, Charlebois A. Testing for natural and synthetic anabolic agents in human urine. J Chromatogr B Biomed Appl 1996; 687 (1): 3–25PubMedCrossRef
5.
go back to reference De Zeeuw RA. Recent developments in analytical toxicology: for better or for worse. Toxicol Lett 1998; 102–108 De Zeeuw RA. Recent developments in analytical toxicology: for better or for worse. Toxicol Lett 1998; 102–108
6.
go back to reference Mottram DR. Banned drugs in sport: does the International Olympic Committee (IOC) list need updating? Sports Med 1999; 27 (1): 1–10PubMedCrossRef Mottram DR. Banned drugs in sport: does the International Olympic Committee (IOC) list need updating? Sports Med 1999; 27 (1): 1–10PubMedCrossRef
8.
go back to reference Bahr R, Tjornhom M. Prevalence of doping in sports: doping control in Norway, 1977–1995. Clin J Sport Med 1998; 8 (1): 32–7PubMedCrossRef Bahr R, Tjornhom M. Prevalence of doping in sports: doping control in Norway, 1977–1995. Clin J Sport Med 1998; 8 (1): 32–7PubMedCrossRef
9.
go back to reference Bruunshuus IK, Klempel K, Cowan D, et al. Transmission of the results of tests for the International Olympic Committee: defined drugs of abuse. J Chromatogr B Biomed Appl 1996; 687 (1): 157–82PubMedCrossRef Bruunshuus IK, Klempel K, Cowan D, et al. Transmission of the results of tests for the International Olympic Committee: defined drugs of abuse. J Chromatogr B Biomed Appl 1996; 687 (1): 157–82PubMedCrossRef
10.
go back to reference Bowers LD. Analytical advances in detection of performance enhancing compounds. Clin Chem 1997; 43 (7): 1299–304PubMed Bowers LD. Analytical advances in detection of performance enhancing compounds. Clin Chem 1997; 43 (7): 1299–304PubMed
11.
go back to reference Maurer HH. Liquid chromatography-mass spectrometry in forensic and clinical toxicology. J Chromatogr B Biomed Sci Appl 1998; 713 (1): 3–25PubMedCrossRef Maurer HH. Liquid chromatography-mass spectrometry in forensic and clinical toxicology. J Chromatogr B Biomed Sci Appl 1998; 713 (1): 3–25PubMedCrossRef
12.
go back to reference Tagliaro F, Turrina S, Pisi P, et al. Determination of illicit and/or abused drugs and compounds of forensic interest in biosamples by capillary electrophoretic/electrokinetic methods. J Chromatogr B Biomed Sci Appl 1998; 713 (1): 27–49PubMedCrossRef Tagliaro F, Turrina S, Pisi P, et al. Determination of illicit and/or abused drugs and compounds of forensic interest in biosamples by capillary electrophoretic/electrokinetic methods. J Chromatogr B Biomed Sci Appl 1998; 713 (1): 27–49PubMedCrossRef
13.
go back to reference Segura J, Ventura R, Jurado C. Derivation procedures for gas chromatographic-mass spectrometric determination of xenobiotics in biological samples, with special attention to drugs of abuse and doping agents. J Chromatogr B Biomed Sci Appl 1998; 713 (1): 61–90PubMedCrossRef Segura J, Ventura R, Jurado C. Derivation procedures for gas chromatographic-mass spectrometric determination of xenobiotics in biological samples, with special attention to drugs of abuse and doping agents. J Chromatogr B Biomed Sci Appl 1998; 713 (1): 61–90PubMedCrossRef
14.
go back to reference Shackleton CH, Roitman E, Phillips A, et al. Androstenediol and 5-androstenediol profiling for detecting exogenously administered dihydrotestosterone, epitestosterone, and dehydroepiandrosterone: potential use in gas chromatography isotope ratio mass spectrometry. Steroids 1997; 62 (10): 665–73PubMedCrossRef Shackleton CH, Roitman E, Phillips A, et al. Androstenediol and 5-androstenediol profiling for detecting exogenously administered dihydrotestosterone, epitestosterone, and dehydroepiandrosterone: potential use in gas chromatography isotope ratio mass spectrometry. Steroids 1997; 62 (10): 665–73PubMedCrossRef
15.
go back to reference Statheropoulos M, Tzamtzis N, Mikedi K. Short column gas chromatograph-mass spectrometry and principal component analysis for the identification of coeluted substances in doping control analysis. J Chromatogr B Biomed Sci Appl 1998; 706 (2): 245–51PubMedCrossRef Statheropoulos M, Tzamtzis N, Mikedi K. Short column gas chromatograph-mass spectrometry and principal component analysis for the identification of coeluted substances in doping control analysis. J Chromatogr B Biomed Sci Appl 1998; 706 (2): 245–51PubMedCrossRef
16.
go back to reference Franke WW, Berendonk B. Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government. Clin Chem 1997; 43 (7): 1262–79PubMed Franke WW, Berendonk B. Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government. Clin Chem 1997; 43 (7): 1262–79PubMed
17.
go back to reference Choi D, Kim M, Park J. Erythropoietin: physico- and biochemical analysis. J Chromatogr B Biomed Appl 1996; 687 (1): 189–99PubMedCrossRef Choi D, Kim M, Park J. Erythropoietin: physico- and biochemical analysis. J Chromatogr B Biomed Appl 1996; 687 (1): 189–99PubMedCrossRef
18.
go back to reference Wide L, Bengtsson C, Berglund B, et al. Detection in blood and urine of recombinant erythropoietin administered to healthy men. Med Sci Sports Exerc 1995; 27 (11): 1569–76PubMed Wide L, Bengtsson C, Berglund B, et al. Detection in blood and urine of recombinant erythropoietin administered to healthy men. Med Sci Sports Exerc 1995; 27 (11): 1569–76PubMed
19.
go back to reference Wu Z, Bidlingmaier M, Dall R, et al. Detection of doping with human growth hormone [letter]. Lancet 1999; 353 (9156): 895PubMedCrossRef Wu Z, Bidlingmaier M, Dall R, et al. Detection of doping with human growth hormone [letter]. Lancet 1999; 353 (9156): 895PubMedCrossRef
20.
go back to reference Garle M, Ocka R, Palonek E, et al. Increased urinary testosterone/epitestosterone ratios found in Swedish athletes in connection with a national control program: evaluation of 28 cases. J Chromatogr B Biomed Appl 1996; 687 (1): 55–9PubMedCrossRef Garle M, Ocka R, Palonek E, et al. Increased urinary testosterone/epitestosterone ratios found in Swedish athletes in connection with a national control program: evaluation of 28 cases. J Chromatogr B Biomed Appl 1996; 687 (1): 55–9PubMedCrossRef
21.
go back to reference Res JJ, Pelders MG, De Smet PA. A case of positive doping associated with a botanical food supplement. Pharm World Sci 1999; 21 (1): 44–6CrossRef Res JJ, Pelders MG, De Smet PA. A case of positive doping associated with a botanical food supplement. Pharm World Sci 1999; 21 (1): 44–6CrossRef
22.
go back to reference Juhn MS, Tarnopolsky M. Oral creatine supplementation and athletic performance: a critical review. Clin J Sport Med 1998; 8 (4): 286–97PubMedCrossRef Juhn MS, Tarnopolsky M. Oral creatine supplementation and athletic performance: a critical review. Clin J Sport Med 1998; 8 (4): 286–97PubMedCrossRef
23.
go back to reference Juhn MS, Tarnopolsky M. Potential side effects of oral creatine supplementation: a critical review. Clin J Sport Med 1998; 8 (4): 298–304PubMedCrossRef Juhn MS, Tarnopolsky M. Potential side effects of oral creatine supplementation: a critical review. Clin J Sport Med 1998; 8 (4): 298–304PubMedCrossRef
24.
go back to reference Tipton CM. Sports medicine: a century of progress. J Nutr 1997; 127 Suppl.: 878–85S Tipton CM. Sports medicine: a century of progress. J Nutr 1997; 127 Suppl.: 878–85S
25.
go back to reference Browne A, Lachance V, Pipe A. The ethics of blood testing as an element of doping control in sport. Med Sci Sports Exerc 1999; 31 (4): 497–501PubMedCrossRef Browne A, Lachance V, Pipe A. The ethics of blood testing as an element of doping control in sport. Med Sci Sports Exerc 1999; 31 (4): 497–501PubMedCrossRef
27.
go back to reference Sachs H, Kintz P. Testing for drugs in hair: critical review of chromatographic procedures since 1992. J Chromatogr B Biomed Sci Appl 1998; 713 (1): 147–61PubMedCrossRef Sachs H, Kintz P. Testing for drugs in hair: critical review of chromatographic procedures since 1992. J Chromatogr B Biomed Sci Appl 1998; 713 (1): 147–61PubMedCrossRef
28.
go back to reference Dukor RK, Liebman MN, Johnson BL. A new, non-destructive method for analysis of clinical samples with FT-IR microspectroscopy: breast cancer tissue as an example. Cell Mol Biol 1998; 44 (1): 211–7PubMed Dukor RK, Liebman MN, Johnson BL. A new, non-destructive method for analysis of clinical samples with FT-IR microspectroscopy: breast cancer tissue as an example. Cell Mol Biol 1998; 44 (1): 211–7PubMed
29.
go back to reference Franck P, Nabet P, Dousset B. Applications of infrared spectroscopy to medical biology. Cell Mol Biol 1998; 44 (2): 273–5PubMed Franck P, Nabet P, Dousset B. Applications of infrared spectroscopy to medical biology. Cell Mol Biol 1998; 44 (2): 273–5PubMed
30.
go back to reference Jackson M, Ramjiawan B, Hewko M, et al. Infrared microscopic functional group mapping and spectral clustering analysis of hypercholesterolemic rabbit liver. Cell Mol Biol 1998; 44 (1): 89–98PubMed Jackson M, Ramjiawan B, Hewko M, et al. Infrared microscopic functional group mapping and spectral clustering analysis of hypercholesterolemic rabbit liver. Cell Mol Biol 1998; 44 (1): 89–98PubMed
31.
go back to reference Sockalingum GD, Bouhedia W, Pina P, et al. FTIR spectroscopy as an emerging method for rapid characterization of microorganisms. Cell Mol Biol 1998; 44 (1): 261–9PubMed Sockalingum GD, Bouhedia W, Pina P, et al. FTIR spectroscopy as an emerging method for rapid characterization of microorganisms. Cell Mol Biol 1998; 44 (1): 261–9PubMed
32.
go back to reference Ward KJ, Haaland DA, Robinson MR, et al. Post-prandial blood glucose determination by quantitative mid-infrared spectroscopy. Applied Spectroscopy 1992; 46 (6): 959–65CrossRef Ward KJ, Haaland DA, Robinson MR, et al. Post-prandial blood glucose determination by quantitative mid-infrared spectroscopy. Applied Spectroscopy 1992; 46 (6): 959–65CrossRef
33.
go back to reference Ward KJ, Haaland DM, Robinson MR, et al. Quantitative infrared spectroscopy of glucose in blood using partial least-squares analyses. SPIE: Fourier Transform Spectroscopy 1989; 1145: 607–8 Ward KJ, Haaland DM, Robinson MR, et al. Quantitative infrared spectroscopy of glucose in blood using partial least-squares analyses. SPIE: Fourier Transform Spectroscopy 1989; 1145: 607–8
34.
go back to reference Shaw RA, Kotowich S, Mantsch HH, et al. Quantitation of protein, creatinine, and urea in urine by near-infrared spectroscopy. Clin Biochem 1996; 29 (1): 11–9PubMedCrossRef Shaw RA, Kotowich S, Mantsch HH, et al. Quantitation of protein, creatinine, and urea in urine by near-infrared spectroscopy. Clin Biochem 1996; 29 (1): 11–9PubMedCrossRef
35.
go back to reference Moore DJ, Gioioso S, Sills RH, et al. Some relationships between membrane phospholipid domains, conformational order, and cell shape in intact human erythrocytes. Biochim Biophys Acta 1999; 1415 (2): 342–8PubMedCrossRef Moore DJ, Gioioso S, Sills RH, et al. Some relationships between membrane phospholipid domains, conformational order, and cell shape in intact human erythrocytes. Biochim Biophys Acta 1999; 1415 (2): 342–8PubMedCrossRef
36.
go back to reference Moore DJ, Sills RH, Mendelsohn R. Conformational order of specific phospholipids in human erythrocytes: correlations with changes in cell shape. Biochemistry 1997; 36 (3): 660–4PubMedCrossRef Moore DJ, Sills RH, Mendelsohn R. Conformational order of specific phospholipids in human erythrocytes: correlations with changes in cell shape. Biochemistry 1997; 36 (3): 660–4PubMedCrossRef
37.
go back to reference Sills RH, Moore DJ, Mendelsohn R. Erythrocyte peroxidation: quantitation by Fourier transform infrared spectroscopy. Anal Biochem 1994; 218 (1): 118–23PubMedCrossRef Sills RH, Moore DJ, Mendelsohn R. Erythrocyte peroxidation: quantitation by Fourier transform infrared spectroscopy. Anal Biochem 1994; 218 (1): 118–23PubMedCrossRef
38.
go back to reference Sockalingum GD, Bouhedja W, Pina P, et al. ATR-FTIR spectroscopic investigation of imipenem-susceptible and -resistant Pseudomonas aeruginosa isogenic strains. Biochem Biophys Res Commun 1997; 232 (1): 240–6PubMedCrossRef Sockalingum GD, Bouhedja W, Pina P, et al. ATR-FTIR spectroscopic investigation of imipenem-susceptible and -resistant Pseudomonas aeruginosa isogenic strains. Biochem Biophys Res Commun 1997; 232 (1): 240–6PubMedCrossRef
39.
go back to reference Budinova G, Salva J, Volka K. Application of molecular spectroscopy in the mid-infrared region to the determination of glucose and cholesterol in whole blood and in blood serum. Appl Spectroscopy 1997; 5: 631–5CrossRef Budinova G, Salva J, Volka K. Application of molecular spectroscopy in the mid-infrared region to the determination of glucose and cholesterol in whole blood and in blood serum. Appl Spectroscopy 1997; 5: 631–5CrossRef
40.
go back to reference Shaw RA, Kotowich S, Leroux M, et al. Multivariate serum analysis using mid-infrared spectroscopy. Ann Clin Biochem 1998; 35: 624–32PubMed Shaw RA, Kotowich S, Leroux M, et al. Multivariate serum analysis using mid-infrared spectroscopy. Ann Clin Biochem 1998; 35: 624–32PubMed
41.
go back to reference Heise HM, Bittner A. Investigation of experimental errors in the quantitative analysis of glucose in human blood plasma by ATR-IR spectroscopy. J Mol Struct 1995; 348: 21–24CrossRef Heise HM, Bittner A. Investigation of experimental errors in the quantitative analysis of glucose in human blood plasma by ATR-IR spectroscopy. J Mol Struct 1995; 348: 21–24CrossRef
42.
go back to reference Petibois C, Rigalleau V, Melin AM, et al. Determination of glucose in dried serum samples by Fourier-transform infrared spectroscopy. Clin Chem 1999; 45 (9): 1530–5PubMed Petibois C, Rigalleau V, Melin AM, et al. Determination of glucose in dried serum samples by Fourier-transform infrared spectroscopy. Clin Chem 1999; 45 (9): 1530–5PubMed
43.
go back to reference Petibois C, Melin AM, Perromat A, et al. Glucose and lactate concentrations determination on single microsamples by Fourier-transform infrared spectroscopy. J Lab Clin Med 2000; 135 (2): 210–5PubMedCrossRef Petibois C, Melin AM, Perromat A, et al. Glucose and lactate concentrations determination on single microsamples by Fourier-transform infrared spectroscopy. J Lab Clin Med 2000; 135 (2): 210–5PubMedCrossRef
44.
go back to reference Petibois C, Cazorla G, Déléris G. New perspectives in sportsmen biological investigations: overtraining prevention using FT-IR spectrometry. Sci Sport. In press Petibois C, Cazorla G, Déléris G. New perspectives in sportsmen biological investigations: overtraining prevention using FT-IR spectrometry. Sci Sport. In press
45.
go back to reference Lipkus AH, Lenk TJ, Chittur KK, et al. Cluster analysis of protein Fourier transform infrared spectra. Biopolymers 1988; 27: 1831–8PubMedCrossRef Lipkus AH, Lenk TJ, Chittur KK, et al. Cluster analysis of protein Fourier transform infrared spectra. Biopolymers 1988; 27: 1831–8PubMedCrossRef
46.
go back to reference Ward JH. Hierarchical grouping to optimize an objective function. J Am Stat Assoc 1963; 58: 236–44CrossRef Ward JH. Hierarchical grouping to optimize an objective function. J Am Stat Assoc 1963; 58: 236–44CrossRef
47.
go back to reference Petibois C, Cazorla G, Déléris G. New perspectives in sportsmen biological investigations: metabolic analysis using FT-IR spectrometry. Sci Sport. In press Petibois C, Cazorla G, Déléris G. New perspectives in sportsmen biological investigations: metabolic analysis using FT-IR spectrometry. Sci Sport. In press
48.
go back to reference Werner GH, Früh J, Keller K, et al. Mid infrared spectroscopy as tool for disease pattern recognition from human blood, in infrared spectroscopy: new tool in medicine. Proceedings of SPIE 3257; 1998 Jan 28–30; San Jose, 35–41 Werner GH, Früh J, Keller K, et al. Mid infrared spectroscopy as tool for disease pattern recognition from human blood, in infrared spectroscopy: new tool in medicine. Proceedings of SPIE 3257; 1998 Jan 28–30; San Jose, 35–41
49.
go back to reference Saugy M, Cardis C, Schweizer C, et al. Detection of human growth hormone doping in urine: out of competition tests are necessary. J Chromatogr B Biomed Appl 1996; 687 (1): 201–11PubMedCrossRef Saugy M, Cardis C, Schweizer C, et al. Detection of human growth hormone doping in urine: out of competition tests are necessary. J Chromatogr B Biomed Appl 1996; 687 (1): 201–11PubMedCrossRef
Metadata
Title
Perspectives in the Utilisation of Fourier-Transform Infrared Spectroscopy of Serum in Sports Medicine
Health Monitoring of Athletes and Prevention of Doping
Authors
Cyril Petibois
Professor Gérard Déléris
Georges Cazorla
Publication date
01-06-2000
Publisher
Springer International Publishing
Published in
Sports Medicine / Issue 6/2000
Print ISSN: 0112-1642
Electronic ISSN: 1179-2035
DOI
https://doi.org/10.2165/00007256-200029060-00002

Other articles of this Issue 6/2000

Sports Medicine 6/2000 Go to the issue

Injury Clinic

Tinea Gladiatorum